2014 (10 POSTS)

Pinto DS, Nicholson G, Harrington RA, Cyr PL, Bhatt DL. CHAMPION PHOENIX Study economic results: Direct hospitalization costs of patients receiving clopidogrel or cangralor during percutaneous coronary intervention. American Heart Association QCOR conference, Baltimore, MD, 2014.

Jensen IS, Wu C, Bay CB, Cyr PL. Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.

Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL, Jensen IS. A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Bay C, Cyr PL, Jensen IS. Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Reichert H, McMahon LF, Meddings J. Did hospital-acquired pressure ulcer rates decrease after implementation of non-payment as a comorbidity with the 2008 Hospital-Acquired Conditions Initiative? Presented at the Academy Health Annual Research Meeting, San Diego, CA, June 2014.

Meddings J, Reichert H, Dueweke E, Rhyner J. 2014. Issues regarding identification of urinary catheter use from medical records. In: Battles JB, Cleeman JI, Kahn KK, Weinberg DA, eds. Advances in the Prevention and Control of Healthcare-Associated Infections. Rockville (MD): Agency for Healthcare Research and Quality (US).

View Abstract

Jensen IS, Halbert RJ, Thompson SF, Hennessy D, Pacconi S, McSweeney PA. Increased use of plerixafor in patients with multiple myeloma and non-Hodgkin’s lymphoma in the United States: A budgetary impact analysis. Abstract C14, Academy of Managed Care Pharmacy 26th Annual Meeting & Expo, 2014.

View Abstract

Reichert H, McMahon LF, Meddings J. Hospital-acquired catheter-associated urinary tract infections: Reported by mandate to the National Healthcare Safety Network, but rarely listed as diagnoses in claims data. Presented at the Society of General Internal Medicine Annual Meeting, San Diego, CA, April 2014.

2013 (8 POSTS)

Jensen IS, Halbert RJ, Grosvenor A, Swartz E, Rossi G, Naoshy S, et al. Incorporating stakeholder input into budget impact models to compare stem cell mobilization strategies. Abstract PCN43, ISPOR 18th Annual International Meeting, 2013.

View Abstract

Meddings J, Reichert H, Hofer T, McMahon L. 2013. Hospital report cards for hospital-acquired pressure ulcers: How good are the grades? Ann Internal Med 159(8):505–513; doi: 10.7326/0003-4819-159-8-201310150-00003. PMID: 24126644.

View Abstract

Kuan RK, Janssen R, Heyward W, Nordyke RJ. 2013. Cost-effectiveness of hepatitis B vaccination using HEPLISAVTM in selected adults compared to Engerix-B® vaccine. Vaccine 31(37):4024-32; doi: 10.1016/j.vaccine.2013.05.014. PMID: 23707166.

View Abstract

Sacks NC, Burgess JF, Cabral HJ, Pizer SD, McDonnell, ME. 2013. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. J Gen Intern Med 28(7):876–885; doi: 10.1007/s11606-013-2342-3. PMID: 23404199.

View Abstract

Olchanski N, McInnis-Myers M, Halseth M, Cyr PL, Bockstedt L, Goss TF, Howland RH. 2013. The economic burden of treatment-resistant depression. Clin Ther 35(4):512-522; doi: 10.1016/j.clinthera.2012.09.001.

View Abstract

Meddings J, Reichert H, Grazier KL, Rogers MAM, Hofer T, McMahon LF. Effect of payment changes for pressure ulcers from the hospital-acquired conditions initiative: A statewide analysis. Presented at the 2013 AcademyHealth Annual Research Meeting, Baltimore, MD, June 2013.

Sacks NC. 2013. Avoidable costs in U.S. healthcare: The $200 billion opportunity from using medicines more responsibly. IMS Health, June.

View Abstract

Cyr P, Sidhu M, Hussain R, Hromin T, Jensen I, Kuan R. Dual-acting osmotic and stimulant laxative for bowel cleansing in an elderly population: A US payer budget impact analysis. Abstract PCN22, ISPOR 18th Annual International Meeting, 2013.

View Abstract

2012 (7 POSTS)

Meddings J, Reichert H, Saint S, McMahon LF. Why are hospital rates of catheter-associated UTIs so low in claims data? Presented at the 2012 Society for Healthcare Epidemiology of America / ID Week, San Diego, CA, October 2012.

Jensen I, Ogborne R, Cyr P. A German hospital budget impact model comparing antibiotic therapies in complicated skin and skin structure infections and bacteremia. ISPOR 17th Annual International Meeting, 2012.

Meddings J, Reichert H, McMahon L. Hospital report cards for hospital-acquired pressure ulcers: How good are the grades? Presented at the 2012 Academy Health Annual Meeting, Orlando, FL, June 2012.

Jensen I, Helm T, Cyr P. Impact of complications in solid organ transplants on hospital charges and length of stay. Abstract PSU15, ISPOR 17th Annual International Meeting, 2012.

View Abstract